xCures Company

The convergence of genomics, precision medicine, and AI have created an unprecedented moment in the world of oncology. But the drug-centric way in which treatments are developed and the haphazard way in which knowledge about those treatments is captured and delivered to the point of care does not serve patients well. xCures is changing that, with an AI-based precision oncology platform that tightly integrates cancer research and care. The xCures platform runs a perpetual trial that captures Real World Evidence (RWE) to continuously learn from all patients, on all treatments, all the time. It coordinates treatment recommendations across all patients and institutions to match patients with the treatments that work. And it packages RWE for use by stakeholders across oncology, slashing the time and cost of drug development and saving lives.
Technology: Artificial Intelligence, Biotechnology, Health Care, Machine Learning, Medical, Pharmaceutical
Industry: Clinical Development
Headquarters: Los Altos, California, United States
Founded Date: 2018-02-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 9
Total Funding: 12965000
Estimated Revenue: $1M to $10M
Last Funding Date: 2021-11-06
Last Funding Type: Series A

Visit Website
Register and Claim Ownership